Search results
Ask the Doctors: Essential tremors not linked to neurological disease
The Daily Reflector· 22 hours agoQ I think I’m coming down with essential tremors, which run in my family. At age 81, my left hand...
Jazz Pharmaceuticals’ essential tremor drug falls flat in Phase IIb trial
Clinical Trials Arena via Yahoo Finance· 2 days agoJazz Pharmaceuticals’ suvecaltamide has failed to meet primary or key secondary endpoints in a Phase...
Jazz Pharmaceuticals Trial for Suvecaltamide in Essential Tremor Misses Primary Endpoint
Market Watch· 3 days agoPublished: June 20, 2024 at 8:15 a.m. ETShareResizeBy Chris WackAbout Dow Jones NewswiresDow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional ...
Jazz Dives — But Key Rival Praxis Surges — On Essential Tremor Drug Failure
Investor's Business Daily· 2 days agoJazz stock toppled Thursday — while shares of rival Praxis Precision Medicines surged — after its ...
Jazz Pharmaceuticals' tremor drug fails in mid-stage study
Reuters via Yahoo News· 3 days agoThe drug, called suvecaltamide, was being tested in adults with essential tremor, a condition that affects the nervous system and causes involuntary and ...
Jazz hits dud note as midphase essential tremor test misses endpoint
FierceBiotech· 3 days agoJazz Pharmaceuticals hit a bum note Thursday, reporting the failure of a phase 2b essential tremor...
Diagnosing essential tremor after death helps fami | Newswise
Newswise· 5 days agoDALLAS – June 18, 2024 – A statistical tool designed to analyze 11 characteristics of postmortem...
Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs
BioPharma Dive via Yahoo Finance· 2 days agoA medicine Jazz acquired in 2019 missed the goal of a Phase 2 study. Elsewhere, Vanda rejected two...
JAZZ Falls as Suvecaltamide Tremor Study Fails to Meet Goals
Zacks via Yahoo Finance· 2 days agoJAZZ shares are down 5% as it fails to achieve statistical significance on the primary and key...
Jazz Pharmaceuticals' phase 2b trial for suvecaltamide fails to meet objectives By Investing.com
Investing.com· 3 days agoJazz Pharmaceuticals plc (NASDAQ:JAZZ) disclosed top-line results from its Phase 2b clinical trial...